Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS(G12D) or KRAS(G12V) mutations

How different KRAS variants impact tumor initiation and progression in vivo has not been thoroughly examined. We hypothesize that the ability of either KRAS(G12D) or KRAS(G12V) mutations to initiate tumor formation is context dependent. Amhr2-Cre mice express Cre recombinase in tissues that develop...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Kun, Eucharist H. S., Tsang, Yvonne T. M., Lin, Sophia, Pan, Sophia, Medapalli, Tejas, Malpica, Anais, Richards, JoAnne S., Gershenson, David M., Wong, Kwong-Kwok
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693266/
https://ncbi.nlm.nih.gov/pubmed/33244099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-77666-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars